AI – A brave new world?

Life Sciences and Health Care Horizons virtual event series

The fast pace of innovation in the life sciences and health care industry has reached an all-time high in 2020 as the industry grapples with the new reality of trying to solve the COVID-19 crisis while also keeping its usual business and science efforts in forward motion.

This global, virtual series aims to tackle the issues shaping the future of the industry. From the impact of the COVID-19 pandemic and outcomes from the U.S. election to supply chain disruption and digital innovation, the series will feature informative presentations, cutting-edge analysis, and engaging virtual discussions.

In recent years, AI has become a buzzword in life sciences and health care as the technology has developed to create applications from drug discovery to diagnostics to therapeutics. Most recently, AI has been used in the fight against the rapid spread of COVID-19.

This session will feature perspectives from special guest speaker, Stacy Schultz, General Counsel, Research & Development at UnitedHealth Group and representatives from the Hogan Lovells global regulatory, product liability, and intellectual property teams, on whether or not new legal strategies are required to harness opportunities or mitigate risks associated with AI. Attendees will leave this session with a practical toolkit to help navigate some of the key legal issues associated with AI.

Register here

Download the Life Sciences and Health Care Horizons guide


More Life Sciences and Health Care Horizons virtual events:

December 16, 2020
Managing supply chain disruptions: Lessons learned in an unstable world

November 19, 2020
Looking ahead to 2021: Impacts of the election for the life sciences and health care industry


Back To Listing
Loading data